development of an improved TB vaccine. The use of high dose challenge for measurement
of efficacy in Non-human primate models brings the risk that vaccines with the potential to be
efficacious against natural challenge could appear ineffective and thus disregarded.
Therefore, there is a need to develop a challenge regimen that is more relevant to natural
human infection. This study has established that ultra-low dose infection of macaques via …